LDN-193188
LDN-193188 is a Phosphatidylcholine transfer protein (PC-TP) inhibitor. LDN-193188 regulates hepatic glucose metabolism, and can be used for study of glucose metabolism[1].
Product Specifications
CAS Number
[1267610-30-9]
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ldn-193188.html
Purity
99.69
Solubility
DMSO : 4.17 mg/mL (ultrasonic)
Smiles
O=C(NC(NC1=CC=C(S(=O)(NC2=NC(C)=CC(C)=N2)=O)C=C1)=O)C3=CC=C(Cl)C=C3Cl
Molecular Formula
C20H17Cl2N5O4S
Molecular Weight
494.35
References & Citations
[1]Shishova EY, et al. Genetic ablation or chemical inhibition of phosphatidylcholine transfer protein attenuates diet-induced hepatic glucose production. Hepatology. 2011;54 (2) :664-674.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
